| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4084924
Max Phase: Preclinical
Molecular Formula: C21H17ClO4
Molecular Weight: 368.82
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C=C1C(=O)Oc2ccc(Cl)cc2[C@H]1[C@@H]1CCc2cc(OC)ccc2C1=O
Standard InChI: InChI=1S/C21H17ClO4/c1-11-19(17-10-13(22)4-8-18(17)26-21(11)24)16-6-3-12-9-14(25-2)5-7-15(12)20(16)23/h4-5,7-10,16,19H,1,3,6H2,2H3/t16-,19+/m0/s1
Standard InChI Key: LBUJVZUSXUHXEL-QFBILLFUSA-N
Associated Targets(Human)
NALM-6 592 Activities
HL-60 67320 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 368.82 | Molecular Weight (Monoisotopic): 368.0815 | AlogP: 4.35 | #Rotatable Bonds: 2 |
| Polar Surface Area: 52.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.78 | CX LogD: 4.78 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.45 | Np Likeness Score: 0.54 |
References
| 1. (2016) 7 (9): [10.1039/C6MD00118A] |
Source
Source(1):